Despite major improvements in transcatheter aortic valve replacement (TAVR)
periprocedural complications in recent years, the occurrence of conduction disturbances has …

In the 16 years since the first pioneering procedure, transcatheter aortic valve implantation
(TAVI) has come of age and become a routine strategy for aortic valve replacement …

Background: Valvular heart disease (VHD) is an important cause of mortality and morbidity
and has been subject to important changes in management. The VHD II survey was …

Background Transcatheter aortic valve replacement (TAVR) use is increasing in patients
with longer life expectancy, yet robust data on the durability of transcatheter heart valves …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

Background: No randomized study powered to compare balloon expandable (BE) with self
expanding (SE) transcatheter heart valves (THVs) on individual end points after …

Aims Transcatheter aortic valve replacement (TAVR) as an alternative to surgical aortic
valve replacement (SAVR) has profoundly changed the management of patients with aortic …

Background and Aim. Conduction disturbances leading to permanent pacemaker
implantation (PPMI) remains a common complication for TAVR procedures, particularly …

Background: Femoral access is the gold standard for transcatheter aortic valve replacement
(TAVR). Guidelines recommend reconsidering surgery when this access is not feasible …

Background Monitoring of microbiological cause of infective endocarditis (IE) remains key in
the understanding of IE; however, data from large, unselected cohorts are sparse. We aimed …